Clean Science and Technology Ltd (CLEAN) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Clean Science & Technology Ltd. demonstrated resilience amidst global trade uncertainties and geopolitical tensions, resulting in extended client decision cycles.
- The company achieved a record high EBITDA margin of over 46% since its listing.
- Established products witnessed robust growth, with a 5% increase sequentially and an 8% increase annually, primarily driven by volume.
- Sales mix was favorable, with established products contributing 83% to standalone sales.
- The company is nearing break-even for its health business, driven by ongoing sales momentum.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.